Researchers uncover new potential biomarker and therapeutic target for aggressive breast cancer
(PhysOrg.com) -- In an analysis of more than 1,300 human breast tissue samples, a team of Stony Brook University School of Medicine researchers discovered a possible role of the squamous cell carcinoma antigen (SCCA) in the progression of breast cancer.
Wei-Xing Zong, Ph.D., Associate Professor, Department of Molecular Genetics & Microbiology, and colleagues found that SCCA expression correlated to both grade and stage of cancer. The finding, reported in the current issue of PLoS One, may be a crucial step to developing SCCA as a biomarker and therapeutic target for aggressive and advanced stage breast cancers.
SCCA is an inhibitor of cellular proteases that digests other proteins. Elevated expression of SCCA has been used in medicine as a biomarker for aggressive squamous cell carcinoma in cancers of the cervix, lung, and head and neck. More recently its expression has also been detected in cancers that are not originated from squamous cells such as liver cancer. The report in PLoS One, titled Elevated expression of squamous cell carcinoma antigen is associated with human breast carcinoma, investigates a new association with elevated expressions of SCCA and cancer.
While there has been significant progress in treating breast cancer, aggressive disease remains difficult to treat and cure, says Dr. Zong. Our findings open the door for SCCA to be explored as a useful marker for predicting outcomes of those suffering from aggressive breast cancers and for SCCA to become a potential therapeutic target to treat cancers unresponsive to current therapies.
Using molecular and pathology analyses, Dr. Zong and colleagues found SCCA expression in breast cancer tissue samples increased when patients had high grade and advanced cancer. They also found that SCCA predicted poor outcomes, as SCCA-positive patients showed shorter overall survival time and shorter time to disease recurrence.
The study included analyses of SCCA expression on 1,360 breast tumor tissue samples and 124 samples of normal breast tissue as controls. Tumors were classified as grades 1, 2, and 3 to define aggressive disease. SCCA expression was observed in only 0.3 percent of grade 1 tumors, but increased to 2.5 percent and 9.4 percent in grades 2 and 3 tumors, respectively.
Regarding SCCA expression in various stages of breast cancer in non-metastatic disease, the progression was similar. SCCA positivity was documented in 2.4 percent of Stage I cancers, 3.1 percent of Stage II cancers, and 8.6 percent of Stage III cancers.
The main findings of the study necessitates further exploration of the role of SCCA in breast cancer development, emphasizes Dr. Zong. He and colleagues are currently studying the biological functions of SCCA in cancer initiation and development. They are also finding that SCCA-expressing cells are specifically sensitive to drugs that induce misfolded proteins. Both research paths may pave the way to developing SCCA as a therapeutic target in aggressive breast cancer.
Collaborating on various SCCA studies are researchers within Dr. Zongs laboratory, as well as researchers in the Departments of Pathology and Preventive Medicine at Stony Brook University School of Medicine.
More information: www.plosone.org/ar… pone.0019096
Provided by Stony Brook University
- Scientists show protein accelerates breast cancer progression in animal models Jun 20, 2007 | not rated yet | 0
- Human Mdm2: A new molecular link to late-stage metastatic breast cancer Dec 02, 2009 | not rated yet | 0
- Smoking does not lead to more aggressive or advanced breast cancers Oct 28, 2007 | not rated yet | 0
- Researcher finds most triple-negative breast cancers express muc-1 target Dec 12, 2008 | not rated yet | 0
- New prognostic marker for human breast cancer Aug 24, 2009 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
Cancer 4 hours ago | not rated yet | 0
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
Cancer 4 hours ago | not rated yet | 0
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
Cancer 19 hours ago | 5 / 5 (2) | 0
(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...
Cancer May 17, 2013 | not rated yet | 0
(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...
Cancer May 17, 2013 | not rated yet | 0 |
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
5 hours ago | not rated yet | 0 |
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
5 hours ago | 4.5 / 5 (2) | 0 |
There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).
4 hours ago | not rated yet | 0
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
19 hours ago | not rated yet | 0 |
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
17 hours ago | not rated yet | 0
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.
17 hours ago | not rated yet | 0